Identifier | 20200309_nanos_sciplatform1_05-slides |
Title | Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (Slides) |
Creator | Eduardo Nicolás Seleme; Michel Sun; John Chen; Anastasia Zekeridou; Elia Sechi; Ryan Walsh; Johanna Beebe; Osama Sabbagh; Luis Mejico; Sean Gratton; Philip Skidd; David Bellows; Julie Falardeau; Clare Fraser; Cecilia Cappelen-Smith; Scott Haines; Bahareh Hassanzadeh; Meagan Seay; Prem Subramanian; Zoë Williams; Lynn Gordon |
Affiliation | (ENS) (MS) (LG) Jules Stein Eye Institute, David Geffen School of Medicine, UCLA, Los Angeles, California; (JC) Department of Ophthalmology, MayoClinic Department of Neurology, Mayo Clinic, Rochester, Minnesota; (AZ) (ES) Department of Neurology, Mayo Clinic, Rochester, Minnesota; (RW) Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin; (JB) Department of Ophthalmology, Park Nicollet Health Services, Minneapolis, Minnesota; (OS) Department of Ophthalmology, University of Kentucky/Retina Associates of Kentucky, Lexington, Kentucky; (LM) Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, New York; (SG) Department of Neurology, University of Missouri-Kansas City, Kansas City, Montana; (PS) Department of Ophthalmology, University of Vermont Medical Center, Burlington, Vermont; (DB) The Medical Eye Center, Manchester, New Hampshire; (JF) Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon; (CF) Department of Ophthalmology, University of Sydney, Sydney, Australia; (CC) Department of Neurology & Neurophysiology, Liverpool Hospital, NSW, Australia; (SH) Department of Neurology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; (BH) Department of Neurology and Ophthalmology, INI Eye center, University of Illinois, Peoria, Illinois; (MS) Department of Ophthalmology, University of Utah, Salt Lake City, Utah; (PS) Department of Ophthalmology, University of Colorado, Aurora, Colorado; (ZW) Department of Ophthalmology, University of Rochester Medical Center, Rochester, New York |
Subject | Optic Neuritis; Myasthenia; Ocular Motility; Orbit; Chemotherapy and Radiation Injury |
Description | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications have been reported in association with checkpoint inhibitor usebut remain incompletely characterized. This study seeks to investigate and further characterize the Neuro-ophthalmic adverse effects from immune checkpoint blockade treatment. |
Date | 2020-03 |
Language | eng |
Format | application/pdf |
Format Creation | Microsoft PowerPoint |
Type | Text |
Source | 2020 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of | NANOS Annual Meeting 2020: Scientific Platform Session I |
Collection | Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher | North American Neuro-Ophthalmology Society |
Holding Institution | Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management | Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK | ark:/87278/s6kh5x58 |
Context URL | The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Setname | ehsl_novel_nam |
ID | 1541334 |
Reference URL | https://collections.lib.utah.edu/ark:/87278/s6kh5x58 |